LPAR5 is upregulated in papillary thyroid carcinoma (PTC), and downregulation of LPAR5 decreases the proliferation and migration phenotype via the PI3K/Akt pathway [34]. This evidence concerns the gene LPAR5 and differentiated thyroid carcinoma.